 PCSK9 degrades LDLR by preventing the hairpin conformational change of LDLR.If PCSK9 does not bind, the receptor will return to the surface of the cell and can continue to remove LDL-particles from the bloodstream.Other variants are associated with a rare autosomal dominant familial hypercholesterolemia (HCHOLA3).